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Abstract
Background: Unhealthy nutrition and lifestyle contribute to the worldwide rising prevalence of non-communicable
diseases. This also accounts for the reproductive population, in which unhealthy behavior affects fertility and pregnancy
outcome. Maternal smoking, alcohol consumption and inadequate folic acid supplement use are strongly associated with
fetal complications as small for gestational age, premature birth and congenital malformations. In the Netherlands 83% of
the perinatal mortality rate is due to these complications and is relatively high compared to other European countries. In
order to reduce this prevalence rate, preconception care should be focused on the promotion of health of prospective
parents by identification and intervention on modifiable nutrition and lifestyle risk factors. We developed the personal
mHealth program ‘Smarter Pregnancy’ (Dutch version available on: https://www.slimmerzwanger.nl) to provide individual
coaching and information to improve nutrition and lifestyle during the preconception period in order to improve health
of the reproductive population and subsequent generations.
Methods: Women between 18 and 45 years of age, and trying to conceive are eligible for inclusion in a randomized
controlled trial. Participants are allocated either to a general population cohort or a subfertile (IVF/ICSI) population cohort.
The intervention group receives personal online coaching based on the identified nutrition and lifestyle risk factors at
baseline. Coaching comprises recipes, incentives, additional questions including feedback and text and e-mail messages,
with a maximum of three per week. The control group only receives one recipe per week to maintain adherence to the
program and prevent drop out. Screening questionnaires are send in both groups at 6, 12, 18, and 24 weeks of the
program to monitor the change in the identified risk factors.
Discussion: We expect to demonstrate that the mHealth program ‘Smarter Pregnancy’ can effectively improve nutrition
and lifestyle in couples contemplating pregnancy. By the identification and improvement of modifiable nutrition and
lifestyle risk factors on a large scale, both reproductive and pregnancy outcomes can be improved and subsequent
perinatal morbidity and mortality rates are expected to be reduced. The current use and rapid development of mHealth
applications offers new opportunities to reach and educate large populations, which can facilitate the implementation of
preconception care.
Trial registration: Dutch trial register: NTR4150. (Registered 19th August 2013)
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Background
Unhealthy nutrition and lifestyle, characterized by a high
caloric intake and vitamin deficiencies, derange metabolic
and endocrine pathways and are causing obesity which
contributes to the development of non-communicable dis-
eases (NCDs), such as cardiovascular and metabolic
diseases [1, 2]. Although awareness of the impact of un-
healthy nutrition and lifestyle is increasing, its prevalence
remains very high, not only in general, but also in the re-
productive population in which health consequences
range from subfertility to congenital malformations or
even perinatal death [3–7]. Most evidence is available on
the detrimental impact of maternal smoking, alcohol con-
sumption and inadequate folic acid supplement use, which
are strongly associated with embryonic growth and small
for gestational age (SGA) and congenital malformations
[8–12]. Currently, several studies that focused on the
adherence of maternal dietary patterns have shown the
benefits of healthy foods such as fruits and vegetables on
perinatal outcome [13, 14].
In the Netherlands, particularly in large cities such as
Rotterdam, perinatal mortality rates and the prevalence
of perinatal complications, such as SGA, premature
birth and congenital malformations (also referred to as
Big3 complications), is relatively high compared to other
European countries [15–17]. In order to reduce these
prevalence rates, preconception care (PCC) should be
implemented, focused on the promotion of health and
the identification of (modifiable) risk factors of prospect-
ive parents as well as the next generation [18–20].
In order to create awareness and to implement PCC
on a large scale, new approaches need to be explored
and (mobile) technologies can be used. Previously, we
developed and implemented a preconception outpatient
clinic tailored to improve nutrition and lifestyle of which
the results were promising, i.e. 30% reduction of inad-
equate nutrition and lifestyle and a 65% increased chance
of ongoing pregnancy after IVF treatment [4, 21].
However, this outpatient clinic could only provide PCC on
a small scale due to the required expertise, time and costs.
To overcome these barriers we have developed the per-
sonal mHealth coaching program ‘Smarter Pregnancy’
(Dutch version available on: www.slimmerzwanger.nl,
English equivalent available on: https://www.smarterpreg-
nancy.co.uk/research/), providing individual, tailored and
continuous information on a large scale during 26 weeks.
Previous studies have shown that women seek online
information with regard to healthy nutrition and life-
style which suggests that online interventions using
mobile technology can be effective [22, 23]. Also,
women embrace online anonymity to control and
self-manage online information [24, 25]. Smarter
Pregnancy identifies the most important risk factors
regarding nutrition and lifestyle and subsequently
provides tailored information and motivational coach-
ing by text and e-mail messages [6].
We hypothesize that our mHealth program will effect-
ively improve nutrition and lifestyle in couples contem-
plating pregnancy. Based on our previous studies and
that of others we designed a randomized controlled trial
(RCT) to study the effectiveness of “Smarter Pregnancy”,
defined as a significant improvement of vegetable and
fruit intake and folic acid supplement use, when started
preconceptional [4, 6, 7, 21, 26]. This intervention can
be considered as a primary prevention tool resulting in a
reduction of Big-3 complications, perinatal morbidity
and mortality in the short-term and NCDs in the long-
term [2, 27, 28].
Objectives
A randomized controlled trial is conducted in two inde-
pendent populations, i.e. couples from the general popu-
lation and couples undergoing IVF/ICSI treatment, to
study whether unhealthy nutrition and lifestyle can be
improved by the Smarter pregnancy coaching program
as an intervention tool. Furthermore, we will determine
whether couples will have a higher pregnancy rate and if
their risk for Big3 complications can be reduced by
improving nutrition and lifestyle.
Primary outcome
Improvement (percentage reduction) of unhealthy nutri-
tion and lifestyle in women and men contemplating
pregnancy or already pregnant, determined by using a
dietary risk score (DRS), 24 weeks after starting the
“Smarter Pregnancy” intervention.
Secondary outcomes
1) A reduction in smoking by women and men contem-
plating pregnancy; 2) pregnancy rates in couples; 3) birth
prevalence rate of Big-3 complications in the entire
study population; 4) cost-effectiveness of the Smarter
Pregnancy intervention.
Tertiary outcomes
The influence of participation of men, pregnancy, age,
low socioeconomic status on the primary outcome and
1) Improvement (defined as the percentage of reduction)
of unhealthy nutrition and lifestyle 36 weeks after start-
ing the “Smarter Pregnancy” intervention; 2) the compli-
ance and reliability of “Smarter Pregnancy” among both
women and men. To study the latter, we aim to deter-
mine the: 1) The percentage of the target group that
meets all the inclusion criteria for the study, but does
not participate; 2) The percentage of participants that is
still participating after three months (compliance); 3)
The prevalence and nature of technical problems.
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Design
Eligibility
Women residing in the Netherlands who are between 18
and 45 years of age and contemplating pregnancy are
considered eligible to be included in this study. To par-
ticipate, women need to be in possession of a smart-
phone with Internet access. Women with insufficient
knowledge or understanding of the Dutch language,
women who are treated by a dietician to lose weight in
the context of a fertility treatment, and women who have
a specific diet (e.g. vegans) cannot participate in the
study. Male partners are also invited to participate, but
only if they meet the same criteria, except that there is
no upper age limit for male participants.
Recruitment, cohort composition and randomization
Women are invited to participate by a (health care) pro-
fessional from their midwifery practice, children’s day-
care, childhealth center, or hospital. Self-registration
through the website is also possible. Potentially eligible
participants are contacted after registration by one of
the researchers to verify their eligibility, to provide more
details and answer questions about “Smarter Pregnancy”
and to confirm their registration.
Participants are allocated either in a general popula-
tion cohort or the IVF/ICSI- (ART) population cohort,
depending on whether they will receive fertility treat-
ment. Randomization of the participants is stratified by
cohort and per center of inclusion. For each stratum a
permuted block design is used and programmed before-
hand. Hereby, allocation concealment is ensured.
Smarter pregnancy
The mHealth program Smarter Pregnancy was launched
in 2012 and provides personal coaching, tailored on per-
sonal conditions, gender, nutrition and lifestyle in both
women and men contemplating pregnancy. The pro-
gram is based on nearly 30 years of research and expert-
ise by our group on the influence of nutrition and
lifestyle on reproduction and pregnancy course and out-
come. We used elements of Prochaska and Diclemente’s
transtheoretical model with a focus on the readiness for
behavioral change, Bandura’s social cognitive theory for
self-efficacy and Fogg’s behavior model to include trig-
gers to motivate and increase the ability to change [29–
31]. Features of the attitude, social influence, and self-
efficacy (ASE) model for coaching are applied; aimed at
the understanding and motives of people to engage in
specific behavior [32].
Intervention group
The content of the individual coaching is based on the
baseline screening on personal conditions, nutrition and
lifestyle and monitoring questionnaires at 6, 12, 18, and
24 weeks of the Smarter Pregnancy program. At these
time points, participants are invited to complete a short,
online questionnaire to monitor the change in their nu-
trition and lifestyle. Results from the questionnaires are
compared with the previous results and shown on a per-
sonal online page to show a participant’s progress.
The tailored coaching includes a maximum of three
interventions per week comprising short message service
(SMS) text and email messages containing tips, recom-
mendations, vouchers, seasonal recipes, and additional
questions addressing behavior, pregnancy status, body
mass index (BMI) or adequacy of the diet (Fig. 1, colored
arrows above black arrows).
The personal page also provides access to additional
modules (i.e. applications) to support physical activity,
an agenda to improve the compliance with hospital ap-
pointments and medicine adherence, and a module to
monitor the safety of prescribed medication. A summary
of all individual results can be obtained at any moment
by the participant, and can be handed over or sent by
email to the health care professional for further evalu-
ation and support of preconception and antenatal care.
Control group
Participants who are randomized in the control group
will not receive personal coaching after the baseline
screening. They do receive access to their personal page
and will receive one seasonal recipe per week to main-
tain adherence and prevent drop out (Fig. 1, lower red
arrows). At baseline as well as at 12 and 24 weeks, par-
ticipants in the control group receive the monitoring
questionnaire about nutrition and lifestyle, but without
feedback on the results. Also, every 6 weeks the controls
receive a request to adjust their pregnancy status if
needed.
Biomarker validation
To validate the self-administered questionnaires, we will
analyze several blood biomarkers in a random sample of
both study populations and both groups (intervention
and control group). A team of qualified medical students
will take blood samples at the participants home address
or at the hospital. These blood samples will be taken on
three time points (t = 0, 12 and 24 weeks) during the
study; each time 20 ml will be collected. Samples are
kept at −20° Celsius for a maximum time period of 4 h.
Aliquots of residual blood will be stored at −80° Celsius
for future research on DNA and epigenetics.
Additional study questionnaires and follow-up
At baseline, for both the intervention and the control
group additional information on social and demographic
characteristics is obtained using an additional online
study questionnaire implemented in the coaching program.
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The first follow-up study questionnaire will be send at
36 weeks, i.e. 12 weeks after the last screening moment
(Fig. 2). One year after enrollment, participants receive their
last study questionnaire, which consists of questions
regarding medical and obstetric history, medication use,
whether they became pregnant during enrollment and, if
applicable, the pregnancy outcome.
Statistical considerations
Sample size calculations are based on our primary out-
come measure (DRS). Based on our previous studies and
the survey using Smarter Pregnancy, we expect a reduc-
tion of approximately 0.5 DRS points (based on a stand-
ard deviation of 2.7) in the intervention group compared
to the control group. Considering alpha = 0.05 and
power = 0.80 we will need to include a total of 916
women in our study (2 arms of 458 each). Due to ex-
pected drop outs of approximately 10%, we aim to in-
clude 1000 fertile (2 arms of 500 each) and 1000
subfertile women (2 arms of 500 each) in our study. For
50% of these women, we expect their male partner
(n = 250 in each arm) to participate as well. Due to
the lower SD (2.0) in men, with this sample size we
are also able to demonstrate a reduction of at least a
0.5 DRS points in the male partners.
Statistical analysis
A flowchart will be used to depict the total participants
of each cohort and divided per group, subdivided per
gender. Also, the amount of resigning participants will
Fig. 1 Overview of the recruitment and composition of the multi-center study and both cohorts
Fig. 2 Overview of both the intervention and control group during their enrollment. The upper arrows pointing downwards depict the intervention
group. The lower arrows pointing upwards depict the control group. All boxed icons depict aspects of the trial that account for all participants in both
groups, i.e. baseline screening, screening questionnaires (at t = 12 and t = 24 weeks), additional questionnaires at baseline and 52 weeks, pregnancy
status per 6 weeks and blood samples (see Additional file 1: SPIRIT-Table)
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be shown per time point (6 weeks). General and baseline
characteristics will be compared between groups and
shown in a baseline table.
The primary analysis will be based on intention to treat
(ITT). For men and women in both the intervention and
the control group the DRS will be calculated at baseline
and after 24 weeks and used for further analyses. This
continuous outcome measure will be analyzed by the ‘dif-
ference in difference principle’ and used in a linear regres-
sion model, including the initial/baseline value of the
DRS. Repeated measurements will be used to investigate
the effects of the intervention over time and the inter-
action of the intervention with socio economic status, eth-
nicity and age. Chi-square analysis and ANCOVA will be
used to study the effects of the intervention on the preg-
nancy outcome and Big-3 complications.
To measure the compliance and reliability of ‘Smarter
pregnancy’ we will analyze the percentage of randomized
women who fill in the questionnaire after 12 weeks of
participation and the percentage of participants who ex-
perienced technical problems. Corresponding confidence
intervals will be given.
The influence on the primary outcome of participation
of men, if pregnancy occurred during participation, age
and low socio economic status will be analyzed by in-
cluding these variables and their interaction with both
groups, one by one in the model which will be used for
the primary outcome. If there is heterogeneity of the
treatment effect, the effect will be determined per sub-
group separately.
Discussion
This study will contribute to the implementation of
easily accessible PCC in order to increase awareness re-
garding the importance of healthy nutrition and lifestyle
in couples contemplating pregnancy and health care
professionals. Subsequently, this can reduce the rela-
tively high rates of perinatal morbidity and mortality
(Big3 complications) in the Netherlands.
Initiating behavioral change(s) by the identification of
risk factors during the preconception period can be a
useful first step to not only create awareness, but also to
lower the threshold to approach a healthcare profes-
sional during this period. Discussing or revealing invol-
untary childlessness remains a burden for many women
as well as for men, due to the perception that they have
failed by not being able to conceive. This results in a
situation in which risk factors for poor reproductive and
pregnancy outcome persist, while adopting a healthy life-
style during this preconception period can be beneficial
on both the short and long term. Most reproductive
failures originate due to deranged metabolic pathways.
The lack of co-factors and substrates as a result of vita-
min deficiencies (e.g. vitamin B12 and folate) can
influence oocyte en semen quality and early embryonic
development resulting in failed implantation and miscar-
riages. Also, it can cause epigenetic modifications to
DNA methylation of the offspring [19, 33, 34]. There-
fore, we consider the preconception period as the win-
dow of opportunity to initiate a healthy lifestyle.
Currently, research in the field of mobile technology is
mainly aimed on the use of mHealth in low- and middle-
income countries, because this new form of health care de-
livery can reach the poorest regions in which the prevalence
of NCDs and poor maternal and child health are the highest
[35–38]. By our opinion, also high income countries com-
prise specific target groups, such as the reproductive popu-
lation, in which risks for poor reproductive and pregnancy
outcome accumulate, because of the lack of knowledge and
self-efficacy with regard to PCC [39]. Therefore, we consider
mHealth a promising method to approach the large group
of reproductive women and men which is currently wrongly
assumed to be at low risk for poor reproductive and preg-
nancy outcome, although it is known that the prevalence of
risk factors in this population is high [4, 6, 11]. Given that
98.6% of all Dutch women and men between 18 and 45 years
old have access to the internet and 96.2% can access the
internet by their mobile phone makes this mHealth ap-
proach justifiable [40].
Strengths of this RCT are the longitudinal observations
and the longitudinal biomarker validation in blood. Also,
additional study questionnaires for short-term and long-
term follow-up (respectively 12 and 26 weeks after the last
questionnaire at 24 weeks), including sociodemographic
data and medical record validation, are considered import-
ant strengths of this study. A limitation of this RCT is the
potential selection bias, which is unfortunately inherent to
participation in a study, especially on behavioral change,
as well as the exclusion of participants without sufficient
knowledge of the Dutch language.
With this RCT we expect to demonstrate the effective-
ness of our Smarter Pregnancy program and its positive ef-
fect on reproductive and pregnancy outcome in both fertile
and subfertile couples. Healthcare professionals are often
also not aware of the importance of PCC nor have tools
containing information and guidelines to provide nutrition
and lifestyle care for medical practice [41]. Therefore, we
consider this study a unique intervention regarding the im-
plementation of accessible preconception care.
Additional file
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